CAR T-Cell Immunotherapy Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hematologic Malignancies
        1.3.3 Solid Malignancies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CAR T-Cell Immunotherapy Market Perspective (2017-2028)
    2.2 CAR T-Cell Immunotherapy Growth Trends by Region
        2.2.1 CAR T-Cell Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2017-2022)
        2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028)
    2.3 CAR T-Cell Immunotherapy Market Dynamics
        2.3.1 CAR T-Cell Immunotherapy Industry Trends
        2.3.2 CAR T-Cell Immunotherapy Market Drivers
        2.3.3 CAR T-Cell Immunotherapy Market Challenges
        2.3.4 CAR T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue
        3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2017-2022)
        3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2017-2022)
    3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
    3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
        3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2021
    3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served
    3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service
    3.7 Date of Enter into CAR T-Cell Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Immunotherapy Breakdown Data by Type
    4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2017-2022)
    4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028)
5 CAR T-Cell Immunotherapy Breakdown Data by Application
    5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2017-2022)
    5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CAR T-Cell Immunotherapy Market Size (2017-2028)
    6.2 North America CAR T-Cell Immunotherapy Market Size by Type
        6.2.1 North America CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
        6.2.2 North America CAR T-Cell Immunotherapy Market Size by Type (2023-2028)
        6.2.3 North America CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    6.3 North America CAR T-Cell Immunotherapy Market Size by Application
        6.3.1 North America CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
        6.3.2 North America CAR T-Cell Immunotherapy Market Size by Application (2023-2028)
        6.3.3 North America CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    6.4 North America CAR T-Cell Immunotherapy Market Size by Country
        6.4.1 North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
        6.4.2 North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe CAR T-Cell Immunotherapy Market Size (2017-2028)
    7.2 Europe CAR T-Cell Immunotherapy Market Size by Type
        7.2.1 Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
        7.2.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2023-2028)
        7.2.3 Europe CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    7.3 Europe CAR T-Cell Immunotherapy Market Size by Application
        7.3.1 Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
        7.3.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2023-2028)
        7.3.3 Europe CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    7.4 Europe CAR T-Cell Immunotherapy Market Size by Country
        7.4.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
        7.4.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2017-2028)
    8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type
        8.2.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application
        8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region
        8.4.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America CAR T-Cell Immunotherapy Market Size (2017-2028)
    9.2 Latin America CAR T-Cell Immunotherapy Market Size by Type
        9.2.1 Latin America CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
        9.2.2 Latin America CAR T-Cell Immunotherapy Market Size by Type (2023-2028)
        9.2.3 Latin America CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    9.3 Latin America CAR T-Cell Immunotherapy Market Size by Application
        9.3.1 Latin America CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
        9.3.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2023-2028)
        9.3.3 Latin America CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country
        9.4.1 Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
        9.4.2 Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2017-2028)
    10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type
        10.2.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application
        10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country
        10.4.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
        11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
        11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.2.5 Celgene Recent Developments
    11.3 Kite Pharma
        11.3.1 Kite Pharma Company Details
        11.3.2 Kite Pharma Business Overview
        11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
        11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.3.5 Kite Pharma Recent Developments
    11.4 Oxford BioMedica
        11.4.1 Oxford BioMedica Company Details
        11.4.2 Oxford BioMedica Business Overview
        11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
        11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.4.5 Oxford BioMedica Recent Developments
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
        11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.5.5 Novartis Recent Developments
    11.6 Gilead
        11.6.1 Gilead Company Details
        11.6.2 Gilead Business Overview
        11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
        11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.6.5 Gilead Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
        11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.7.5 Pfizer Recent Developments
    11.8 Cellectis
        11.8.1 Cellectis Company Details
        11.8.2 Cellectis Business Overview
        11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
        11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.8.5 Cellectis Recent Developments
    11.9 Bellicum
        11.9.1 Bellicum Company Details
        11.9.2 Bellicum Business Overview
        11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
        11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.9.5 Bellicum Recent Developments
    11.10 Mustang Bio
        11.10.1 Mustang Bio Company Details
        11.10.2 Mustang Bio Business Overview
        11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
        11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.10.5 Mustang Bio Recent Developments
    11.11 CARsgen Therapeutics
        11.11.1 CARsgen Therapeutics Company Details
        11.11.2 CARsgen Therapeutics Business Overview
        11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
        11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.11.5 CARsgen Therapeutics Recent Developments
    11.12 Xyphos
        11.12.1 Xyphos Company Details
        11.12.2 Xyphos Business Overview
        11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
        11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.12.5 Xyphos Recent Developments
    11.13 Minerva Biotechnologies
        11.13.1 Minerva Biotechnologies Company Details
        11.13.2 Minerva Biotechnologies Business Overview
        11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
        11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.13.5 Minerva Biotechnologies Recent Developments
    11.14 Adaptimmune
        11.14.1 Adaptimmune Company Details
        11.14.2 Adaptimmune Business Overview
        11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
        11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.14.5 Adaptimmune Recent Developments
    11.15 Ziopharm Oncology
        11.15.1 Ziopharm Oncology Company Details
        11.15.2 Ziopharm Oncology Business Overview
        11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
        11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.15.5 Ziopharm Oncology Recent Developments
    11.16 Aurora Biopharma
        11.16.1 Aurora Biopharma Company Details
        11.16.2 Aurora Biopharma Business Overview
        11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
        11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.16.5 Aurora Biopharma Recent Developments
    11.17 Creative Biolabs
        11.17.1 Creative Biolabs Company Details
        11.17.2 Creative Biolabs Business Overview
        11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
        11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        11.17.5 Creative Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2017-2022)
    Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2023-2028)
    Table 10. CAR T-Cell Immunotherapy Market Trends
    Table 11. CAR T-Cell Immunotherapy Market Drivers
    Table 12. CAR T-Cell Immunotherapy Market Challenges
    Table 13. CAR T-Cell Immunotherapy Market Restraints
    Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global CAR T-Cell Immunotherapy Revenue Share by Players (2017-2022)
    Table 16. Global Top CAR T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021)
    Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service
    Table 21. Date of Enter into CAR T-Cell Immunotherapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2017-2022)
    Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2023-2028)
    Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global CAR T-Cell Immunotherapy Revenue Share by Application (2017-2022)
    Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global CAR T-Cell Immunotherapy Revenue Share by Application (2023-2028)
    Table 31. North America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific CAR T-Cell Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie CAR T-Cell Immunotherapy Product
    Table 64. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 65. AbbVie Recent Developments
    Table 66. Celgene Company Details
    Table 67. Celgene Business Overview
    Table 68. Celgene CAR T-Cell Immunotherapy Product
    Table 69. Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 70. Celgene Recent Developments
    Table 71. Kite Pharma Company Details
    Table 72. Kite Pharma Business Overview
    Table 73. Kite Pharma CAR T-Cell Immunotherapy Product
    Table 74. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 75. Kite Pharma Recent Developments
    Table 76. Oxford BioMedica Company Details
    Table 77. Oxford BioMedica Business Overview
    Table 78. Oxford BioMedica CAR T-Cell Immunotherapy Product
    Table 79. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 80. Oxford BioMedica Recent Developments
    Table 81. Novartis Company Details
    Table 82. Novartis Business Overview
    Table 83. Novartis CAR T-Cell Immunotherapy Product
    Table 84. Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 85. Novartis Recent Developments
    Table 86. Gilead Company Details
    Table 87. Gilead Business Overview
    Table 88. Gilead CAR T-Cell Immunotherapy Product
    Table 89. Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 90. Gilead Recent Developments
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer CAR T-Cell Immunotherapy Product
    Table 94. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 95. Pfizer Recent Developments
    Table 96. Cellectis Company Details
    Table 97. Cellectis Business Overview
    Table 98. Cellectis CAR T-Cell Immunotherapy Product
    Table 99. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 100. Cellectis Recent Developments
    Table 101. Bellicum Company Details
    Table 102. Bellicum Business Overview
    Table 103. Bellicum CAR T-Cell Immunotherapy Product
    Table 104. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 105. Bellicum Recent Developments
    Table 106. Mustang Bio Company Details
    Table 107. Mustang Bio Business Overview
    Table 108. Mustang Bio CAR T-Cell Immunotherapy Product
    Table 109. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 110. Mustang Bio Recent Developments
    Table 111. CARsgen Therapeutics Company Details
    Table 112. CARsgen Therapeutics Business Overview
    Table 113. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
    Table 114. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 115. CARsgen Therapeutics Recent Developments
    Table 116. Xyphos Company Details
    Table 117. Xyphos Business Overview
    Table 118. Xyphos CAR T-Cell Immunotherapy Product
    Table 119. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 120. Xyphos Recent Developments
    Table 121. Minerva Biotechnologies Company Details
    Table 122. Minerva Biotechnologies Business Overview
    Table 123. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
    Table 124. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 125. Minerva Biotechnologies Recent Developments
    Table 126. Adaptimmune Company Details
    Table 127. Adaptimmune Business Overview
    Table 128. Adaptimmune CAR T-Cell Immunotherapy Product
    Table 129. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 130. Adaptimmune Recent Developments
    Table 131. Ziopharm Oncology Company Details
    Table 132. Ziopharm Oncology Business Overview
    Table 133. Ziopharm Oncology CAR T-Cell Immunotherapy Product
    Table 134. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 135. Ziopharm Oncology Recent Developments
    Table 136. Aurora Biopharma Company Details
    Table 137. Aurora Biopharma Business Overview
    Table 138. Aurora Biopharma CAR T-Cell Immunotherapy Product
    Table 139. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 140. Aurora Biopharma Recent Developments
    Table 141. Creative Biolabs Company Details
    Table 142. Creative Biolabs Business Overview
    Table 143. Creative Biolabs CAR T-Cell Immunotherapy Product
    Table 144. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 145. Creative Biolabs Recent Developments
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2021 VS 2028
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2021 VS 2028
    Figure 5. Hematologic Malignancies Case Studies
    Figure 6. Solid Malignancies Case Studies
    Figure 7. CAR T-Cell Immunotherapy Report Years Considered
    Figure 8. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global CAR T-Cell Immunotherapy Market Share by Region: 2021 VS 2028
    Figure 11. Global CAR T-Cell Immunotherapy Market Share by Players in 2021
    Figure 12. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2021
    Figure 14. North America CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 16. North America CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 17. North America CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028)
    Figure 18. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 22. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 23. Europe CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028)
    Figure 24. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific CAR T-Cell Immunotherapy Market Size Share by Region (2017-2028)
    Figure 34. China CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 40. Latin America CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028)
    Figure 44. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa CAR T-Cell Immunotherapy Market Size Share by Country (2017-2028)
    Figure 50. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 54. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 55. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 56. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 58. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 60. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 61. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 62. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 63. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 64. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 65. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 66. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 67. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 68. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 69. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed